Chia-Hao Su

Simple synthesis and functionalization of iron nanoparticles for magnetic resonance imaging.

Magnetic nanoparticles (NPs) are increasingly important in many biomedical applications, such as drug delivery, hyperthermia, and magnetic resonance imaging (MRI) contrast enhancement. For MRI, iron oxide NPs are the only commercial T2 or negative contrast agents, due to their biocompatibility and ease of synthesis and research in the area is highly active. The efficacy of these contrast agents depends mainly on the surface chemistry and magnetic properties of the NPs. Materials with larger magnetization could induce more efficient transverse (T2) relaxation of protons and result in greater contrast enhancement. As iron has the highest saturation magnetization at room temperature among all elements, and is biocompatible, it is an ideal candidate for MRI contrast enhancement. Nevertheless, the development of using iron NPs for magnetic applications has been challenging and limited compared to those of its oxides, due to the difficulty in preparing stable iron NPs with simple synthesis methods and precursors. 6] Under ambient conditions, iron NPs of 8 nm or smaller oxidize completely upon exposure to air. For larger NPs, an oxide shell of 3–4 nm forms instantly on the surface, forming iron/iron oxide core/shell NPs. Groundbreaking studies for the synthesis of iron NPs of larger than 8 nm has largely been achieved by decomposition of iron pentacarbonyl, [Fe(CO)5]. [6,8] Additional reports include the use of other precursors in forming iron nanocubes. However, all of these processes are limited in terms of ease of synthesis and scalability; [Fe(CO)5] is volatile and highly toxic, [5] and other processes involve precursors that are expensive and airsensitive, or require high decomposition temperatures. Here, we chose an easy to handle iron organometallic sandwich compound as the precursor and prepared singlecrystal iron NPs using a simple, low-temperature synthesis method. The iron nanocrystals oxidized naturally to form highly crystalline iron/iron oxide core/shell NPs. The ease of this synthesis facilitates the larger-scale application of stabilized iron NPs. To enable the use of these NPs in biological applications, the NP surface was modified to make the NPs water soluble. The strongly magnetic core/shell NPs are shown to be more effective T2 contrast agents for in vivo MRI and small tumor detection, compared to pure iron oxides. The successful detection of small tumors in vivo demonstrated here holds a great promise for accurate detection of early metastases in human lymph nodes, which has a large impact on the treatment and prognosis of a range of cancers. The iron/iron oxide core/shell NPs were prepared by first synthesizing iron nanocrystals by decomposition of the iron precursor [Fe(C5H5)(C6H7)], in the presence of oleylamine (OLA) stabilizing molecules. The non-carbonyl, sandwich compound was chosen for its simple preparation and ease of decomposition compared to other more stable sandwich compounds such as ferrocene. The synthesis was carried out in a closed reaction vessel under a mild hydrogen atmosphere, at 130 8C. The temperature required was lower than the usual temperature range (150–300 8C) needed for decomposition of other iron precursors in previous studies. Once [*] Dr. K. W. Feindel, Prof. P. T. Callaghan, Prof. R. D. Tilley School of Chemical and Physical Sciences and The MacDiarmid Institute for Advanced Materials and Nanotechnology, Victoria University of Wellington, Wellington 6012 (New Zealand) Fax: (+ 64)4-463-5237 E-mail: richard.tilley@vuw.ac.nz Dr. S. Cheong, Dr. B. Ingham Industrial Research Limited and The MacDiarmid Institute for Advanced Materials and Nanotechnology P. O. Box 31-310, Lower Hutt 5040 (New Zealand) Dr. P. Ferguson, Dr. I. F. Hermans Malaghan Institute of Medical Research P. O. Box 7060, Wellington 6012 (New Zealand)

Enhancing transversal relaxation for magnetite nanoparticles in mr imaging using Gd3+-chelated mesoporous silica shells

A new magnetic nanoparticle was synthesized in the form of Gd(3+)-chelated Fe(3)O(4)@SiO(2). The Fe(3)O(4) nanoparticle was octahedron-structured, was highly magnetic (∼94 emu/g), and was the core of an encapsulating mesoporous silica shell. DOTA-NHS molecules were anchored to the interior channels of the porous silica to chelate Gd(3+) ions. Because there were Gd(3+) ions within the silica shell, the transverse relaxivity increased 7-fold from 97 s(-1) mM(-1) of Fe(3)O(4) to 681 s(-1) mM(-1) of Gd(3+)-chelated Fe(3)O(4)@SiO(2) nanoparticles with r(2)/r(1) = 486. The large transversal relaxivity of the Gd(3+)-chelated Fe(3)O(4)@SiO(2) nanoparticles had an effective magnetic resonance imaging effect and clearly imaged lymph nodes. Physiological studies of liver, spleen, kidney, and lung tissue in mice infused with these new nanoparticles showed no damage and no cytotoxicity in Kupffer cells, which indicated that Gd(3+)-chelated Fe(3)O(4)@SiO(2) nanoparticles are biocompatible.

Solid-state synthesis of monocrystalline iron oxide nanoparticle based ferrofluid suitable for magnetic resonance imaging contrast application

A new γ-Fe2O3 MION ferrofluid has been developed with a salt-assisted solid-state reaction. Characterizations show that the ferrofluid is composed of maghemite nanoparticles with a mean diameter of 2.7 nm. Though the nanoparticles are ultrafine, they are well crystallized, with a saturation magnetization value of 34.7 emu g−1, making them suitable for MRI applications. In spite of the absence of any surfactant, the ferrofluid can be stable for more than 6 months. An in vitro cytotoxicity test revealed good biocompatibility of the maghemite nanoparticles, suggesting that they may be further explored for biomedical applications. NMR measurements revealed significantly reduced water proton relaxation times T1 and T2. The MR images of the nanoparticles in aqueous dispersion were investigated using a 3 T clinical MR imager. These preliminary experiments have demonstrated the potential of the as-synthesized ultrafine, cap-free maghemite MIONs in functional molecular imaging for biomedical research and clinical diagnosis.

Aqueous nickel-nitrilotriacetate modified Fe3O4–NH3+ nanoparticles for protein purification and cell targeting

A comprehensive totally aqueous phase synthesis of nickel-nitrilotriacetate (Ni-NTA) modified superparamagnetic Fe(3)O(4) nanoparticles is presented. The Fe(3)O(4)-NTA-Ni nanoparticles are able to perform efficient and specific purification of 6-His tagged proteins from crude cell lysates, as evidenced by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis. The average binding capacity, as demonstrated by streptopain (M(W) 42xa0kDa), is 0.23xa0mg/mg (protein/Fe(3)O(4)-NTA-Ni). Considering the high affinity and specificity of the binding between hexahistidine motif and Ni-NTA, Ni-NTA modified nanoparticles could act as a module to carry 6-His tagged proteins on the particle surface with molecular orientation control, since only the 6-His domain could be attached. These modularly designed functional nanoparticles enhance cancer cell targeting, as supported by the in vitro receptor mediated targeting assay using RGD-4C-6-His fusion peptide. The nanoparticles show no significant hemolysis for human blood and could be investigated further for their in vivo functional imaging applications.

Quantitative Susceptibility Mapping-Based Microscopy of Magnetic Resonance Venography (QSM-mMRV) for In Vivo Morphologically and Functionally Assessing Cerebromicrovasculature in Rat Stroke Model

Abnormal cerebral oxygenation and vessel structure is a crucial feature of stroke. An imaging method with structural and functional information is necessary for diagnosis of stroke. This study applies QSM-mMRV (quantitative susceptibility mapping-based microscopic magnetic resonance venography) for noninvasively detecting small cerebral venous vessels in rat stroke model. First, susceptibility mapping is optimized and calculated from magnetic resonance (MR) phase images of a rat brain. Subsequently, QSM-mMRV is used to simultaneously provide information on microvascular architecture and venous oxygen saturation (SvO2), both of which can be used to evaluate the physiological and functional characteristics of microvascular changes for longitudinally monitoring and therapeutically evaluating a disease model. Morphologically, the quantification of vessel sizes using QSM-mMRV was 30% smaller than that of susceptibility-weighted imaging (SWI), which eliminated the overestimation of conventional SWI. Functionally, QSM-mMRV estimated an average SvO2 ranging from 73% to 85% for healthy rats. Finally, we also applied QSM to monitor the revascularization of post-stroke vessels from 3 to 10 days after reperfusion. QSM estimations of SvO2 were comparable to those calculated using the pulse oximeter standard metric. We conclude that QSM-mMRV is useful for longitudinally monitoring blood oxygen and might become clinically useful for assessing cerebrovascular diseases.

Dynamic Contrast Enhanced Imaging of Mice Kidney Metabolism Using High-Temperature Superconducting RF Coil on a 3T MRI System

Dynamic contrast enhanced (DCE) MRI is a potential technique to monitor the temporal evolution of signal change for the specific tissue microcirculation or tumor angiogenesis. In this study, we implemented high-temperature superconducting (HTS) RF coil system on DCE application of in-vivo mice kidney metabolism. Compared to a conventional copper coil, the improvement of the signal-to-noise ratio (SNR) of approximately 2.7 folds and average signal change (DeltaS) of 4 folds was shown in the preliminary results. The capability of HTS coil on DCE MRI was demonstrated and further investigation of tumor cancer model is expected.